BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Brandon Folkes does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ADILAdial Pharmaceuticals Inc | Buy | $8.00 | Nov 2024 | −78.3% | Miss |
 RMTIRockwell Medical Inc | Buy | $5.00 | Nov 2024 | −70.0% | Miss |
 ACHVAchieve Life Sciences Inc | Buy | $12.00 | Nov 2024 | −5.9% | Miss |
 EPRXEupraxia Pharmaceuticals Inc. Common Stock | Buy | $9.00 | Nov 2024 | +93.4% | Miss |
 EBSEmergent Biosolutions Inc | Buy | $16.00 | Sep 2024 | +21.8% | Miss |
 CRMDCorMedix Inc | Buy | $13.00 | Aug 2024 | +137.2% | Hit |
 MISTMilestone Pharmaceuticals Inc | Buy | $9.00 | Aug 2024 | +25.3% | Miss |
 HRTXHeron Therapeuti | Buy | $7.00 | Jun 2024 | −41.2% | Miss |
 SCLXScilex Holding Company | Buy | $13.00 | Jun 2024 | −86.3% | Miss |
 RANIRani Therapeutics Holdings Inc | Buy | $10.00 | Jun 2024 | −81.8% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.